Objective Combination therapy with rituximab and belimumab is a novel treatment strategy for severe SLE and lupus nephritis.

The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.

Obinutuzumab could reshape the treatment of lupus nephritis, a life-threatening complication of lupus that has long lacked ...

Genentech has shared positive data from the Phase III REGENCY trial with regulators in the US and EU. Roche’s subsidiary ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that a detailed analysis of its phase III REGENCY trial of Gazyva®/Gazyvaro® (obinutuzumab) in people with active lupus nephritis (LN) was published ...

Hypoglycemia (low blood sugar) is not a formal symptom of lupus, but it may develop from related factors like medication use, other autoimmune processes in the body, and hormonal changes.

Methods: Google Trends™ were used to analyze search activity from January 2004 to December 2024 for IgA nephropathy (IgAN), membranous glomerulonephritis (MN), focal segmental glomerulosclerosis (FSGS ...

[1] In previous years, randomized, controlled trials (RCTs) at the NIH and other institutions, mainly involving patients with severe lupus nephritis, have demonstrated the superiority of the ...

In spite of considerable achievements, treatment of established lupus is a difficult task. Complete remission of mild disease with mucocutaneus or joint disease remains a challenge with a ...

Results In the exploratory cohort, serum levels of NGAL were increased in patients with SLE as compared with healthy controls (p=0.021), and associated with histological-proven membranoproliferative ...

Lupus panniculitis is a rare type of lupus. It causes painful lumps under the skin that may lead to scarring. Treatments can help reduce the risk of complications. Lupus is a chronic autoimmune ...